These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32641846)

  • 1. Danish bispecifics meet ADCs.
    Nat Biotechnol; 2020 Jul; 38(7):774. PubMed ID: 32641846
    [No Abstract]   [Full Text] [Related]  

  • 2. Bispecific antibodies and ADCs: Once and future kings?
    Reichert JM
    MAbs; 2011; 3(4):329-30. PubMed ID: 21654205
    [No Abstract]   [Full Text] [Related]  

  • 3. Emerging new therapeutic antibody derivatives for cancer treatment.
    Jin S; Sun Y; Liang X; Gu X; Ning J; Xu Y; Chen S; Pan L
    Signal Transduct Target Ther; 2022 Feb; 7(1):39. PubMed ID: 35132063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.
    Sharkey RM; Rossi EA; Chang CH; Goldenberg DM
    Cancer Biother Radiopharm; 2010 Feb; 25(1):1-12. PubMed ID: 20187791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comments on the Fourth International Conference on Bispecific Antibodies and Cellular Cytotoxicity, Duck Key, Florida, March 1-5, 1995.
    Fanger MW; Ball ED; Drakeman DL
    J Hematother; 1995 Oct; 4(5):345-9. PubMed ID: 8581367
    [No Abstract]   [Full Text] [Related]  

  • 6. Coming-of-Age of Antibodies in Cancer Therapeutics.
    Ayyar BV; Arora S; O'Kennedy R
    Trends Pharmacol Sci; 2016 Dec; 37(12):1009-1028. PubMed ID: 27745709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer therapy with antibodies.
    Paul S; Konig MF; Pardoll DM; Bettegowda C; Papadopoulos N; Wright KM; Gabelli SB; Ho M; van Elsas A; Zhou S
    Nat Rev Cancer; 2024 Jun; 24(6):399-426. PubMed ID: 38740967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celgene wagers on Sutro's cell-free platform to ramp up ADCs.
    Ratner M
    Nat Biotechnol; 2014 Dec; 32(12):1175. PubMed ID: 25489819
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on novel monoclonal antibodies and immunoconjugates for the treatment of lymphoproliferative disorders.
    Derby L; Czuczman MS
    Future Oncol; 2011 Aug; 7(8):963-79. PubMed ID: 21823892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates.
    Cheal SM; Xu H; Guo HF; Lee SG; Punzalan B; Chalasani S; Fung EK; Jungbluth A; Zanzonico PB; Carrasquillo JA; O'Donoghue J; Smith-Jones PM; Wittrup KD; Cheung NV; Larson SM
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):925-937. PubMed ID: 26596724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation antibody drugs: pursuit of the 'high-hanging fruit'.
    Carter PJ; Lazar GA
    Nat Rev Drug Discov; 2018 Mar; 17(3):197-223. PubMed ID: 29192287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in the study of Her2-targeted cancer therapeutic antibodies].
    Chang L; Li CH; Gao J
    Yao Xue Xue Bao; 2015 May; 50(5):516-20. PubMed ID: 26234129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symmetry breaking: bispecific antibodies, the beginnings, and 50 years on.
    Riethmüller G
    Cancer Immun; 2012; 12():12. PubMed ID: 22896757
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting T cells to tumor cells using bispecific antibodies.
    Frankel SR; Baeuerle PA
    Curr Opin Chem Biol; 2013 Jun; 17(3):385-92. PubMed ID: 23623807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merck KGaA, F-Star shake on immune-oncology bispecifics.
    Nat Biotechnol; 2017 Jul; 35(7):601. PubMed ID: 28700541
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA.
    Parren PW; Burton DR; Bradbury A; Huston JS; Carter PJ; Veldman T; Chester KA; Larrick JW; Alfenito MR; Scott JK; Weiner LM; Adams GP; Reichert JM
    MAbs; 2015; 7(6):981-8. PubMed ID: 26421752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A universal pretargeting system for cancer detection and therapy using bispecific antibody.
    Sharkey RM; McBride WJ; Karacay H; Chang K; Griffiths GL; Hansen HJ; Goldenberg DM
    Cancer Res; 2003 Jan; 63(2):354-63. PubMed ID: 12543788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Site Specific Conjugations of Antibody Drug Conjugates (ADCs).
    Gao W; Zhang J; Xiang J; Zhang L; Wu C; Dhal PK; Chen B
    Curr Cancer Drug Targets; 2016; 16(6):469-79. PubMed ID: 27174056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to Antibody-Drug Conjugates.
    García-Alonso S; Ocaña A; Pandiella A
    Cancer Res; 2018 May; 78(9):2159-2165. PubMed ID: 29653942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weaponized antibodies use new tricks to fight cancer.
    Ledford H
    Nature; 2016 Nov; 540(7631):19-20. PubMed ID: 27905466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.